The Chinese Government’s wide-ranging bribery and corruption investigation into the pharmaceutical industry takes a new turn every week. Media reports contain numerous incidents of purported whistleblowers making allegations...more
The Chinese government’s recent crackdown on alleged bribery and corruption of local officials by multinational pharmaceutical companies could signal a broad trend toward elevated scrutiny of all foreign corporations...more
McDermott Will & Emery has a strategic alliance with MWE China Law Offices, a separate law firm based in Shanghai.
"Distribution in China – Legal Issues” is a four-part series. Part I discussed the business models...more